argenx SE logo

argenx SE

ARGX
Healthcare|Biotechnology|Netherlands
$877.29
-31.87 (-3.50%)
DCF (FCF)
$17.80
Tangible Book
$111.77
Graham Number
$215.25

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 6031.72, 7372.55, 8664.37, 9900.44, 11207.27 ], "ebit_estimate": [ 1903.74, 2465.21, 3262, 4041.97, 5055.31 ], "ebitda_estimate": [ 1941.51, 2413.67, 3221.45, 4221.74, 4855 ], "net_income_estimate": [ 1776.34, 2375.13, 3013.89, 3503.33, 4341.22 ], "per_share_eps_estimate": [ 26.87, 34.71, 45.58, 49.61, 60.24 ], "eps_nri_estimate": [ 26.22, 35.6, 43.31, 50.13, 64.67 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 146.95, 183.42, 240.47, 330.85, 416.09 ], "pretax_income_estimate": [ 2057.1, 2762.48, 3519.49, 4250.73, 5325.57 ], "operating_cash_flow_per_share_estimate": [ 30.15, 36.99, 47.06, 70.76, 79.56 ], "roa_estimate": [ 19.48, 20.58, 18.5, 18.9, 18.7 ], "roe_estimate": [ 22.64, 22.86, 20.91, 20.53, 19.77 ], "gross_margin_estimate": [ 89.53, 89.46, 88.52, 90.4, 90.4 ], "operating_cash_flow_estimate": [ 2000.66, 2454.43, 3122.93, 4695.09, 5279.03 ], "pettm_estimate": [ 32.65, 25.28, 19.25, 17.68, 14.56 ], "long_term_growth_rate_mean": 32.84, "long_term_revenue_growth_rate_mean": "26.85", "future_per_share_eps_estimate_growth": 33.65, "future_eps_nri_estimate_growth": 32.84, "future_revenue_estimate_growth": 26.85, "future_ebit_estimate_growth": 46.22, "future_ebitda_estimate_growth": 45.47, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 34.41, "future_pretax_income_estimate_growth": 42.21, "future_book_value_per_share_estimate_growth": 27.72, "future_roa_estimate_growth": 2.19, "future_roe_estimate_growth": 3.97, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 63.39 }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 1442.69, 1567.11, 1692.72, 1712.47, 1815.05, 1883.01, 1973.74, 1964.11 ], "ebit_estimate": [ 435.14, 502.85, 540.8, 567.13, 637.68, 696.14, 790.41, null ], "ebitda_estimate": [ 434.72, 500.27, 509.1, null, null, null, null, null ], "net_income_estimate": [ 409.97, 462.52, 498.81, 500.61, 574.67, 624.57, 706.37, null ], "per_share_eps_estimate": [ 6.19, 7.02, 7.54, 7.74, 8.7, 9.28, 10.23, null ], "eps_nri_estimate": [ 6.15, 6.87, 7.49, 7.45, 8.38, 8.86, 9.81, 11.64 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 91.89, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 478, 539.92, 578.34, 596.9, 684.45, 743.24, 838.51, null ], "operating_cash_flow_per_share_estimate": [ 6.09, 7.14, 6.41, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ 50.4, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 89.47, 89.47, 88.96, 91, 91, 91, 89, null ], "operating_cash_flow_estimate": [ 404.11, 473.79, 425.35, null, null, null, null, null ], "pettm_estimate": [ 30.8, 28.31, 26.38, 24.4, null, null, null, null ], "long_term_growth_rate_mean": 32.84, "long_term_revenue_growth_rate_mean": "26.85", "future_per_share_eps_estimate_growth": 33.65, "future_eps_nri_estimate_growth": 32.84, "future_revenue_estimate_growth": 26.85, "future_ebit_estimate_growth": 46.22, "future_ebitda_estimate_growth": 45.47, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 34.41, "future_pretax_income_estimate_growth": 42.21, "future_book_value_per_share_estimate_growth": 27.72, "future_roa_estimate_growth": 2.19, "future_roe_estimate_growth": 3.97, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 63.39 }

News

2026-07-07 16:33:05
2026-07-02 15:31:17
2026-07-01 11:30:44
2026-06-25 13:00:31
2026-06-24 13:33:25